Emergency Medicine: Open Access
Open Access

Leandro Rodriguez

Publications

• Research Article
  Flecainide versus Electrical Cardio Version in Patients with a Recent-Onset Atrial Fibrillation
  Author(s): Diego Conde, Nicolas Lalor, Leandro Rodriguez and Pablo ElissamburuDiego Conde, Nicolas Lalor, Leandro Rodriguez and Pablo Elissamburu
  
  Introduction: Flecainide is a Class IA drug according the European Guidelines for conversion of recent-onset atrial fibrillation in patients without structural heart disease. Electrical Cardio version is the first line in many centers in all over the world in this population. Up to the present no study has been conducted comparing Flecainide with Electrical Cardio version (EC) for conversion of recent-onset atrial fibrillation. The goal of our study was to compare the conversion rate of recent-onset AF, hospital stay length and adverse events in hemodynamically stable patients without structural heart disease treated with flecainide or EC. Methods: 50 hemodynamically stable patients with recent onset AF without structural heart disease were included. 30 patients received oral loading dose of flecainide 300 mg and other 20 patie.. View More»
  DOI: 10.4172/2165-7548.1000150

  Abstract PDF

Relevant Topics